Share on twitter
SHARE
Share on linkedin
SHARE
Share on twitter
SHARE
Share on linkedin
SHARE

Integra Therapeutics at ‘Pharmaceutical Technology’

Integra Therapeutics at ‘Pharmaceutical Technology’

Pharmaceutical Technology review publishes an article entitled Integra Therapeutics Q&A: building next-generation gene editing tools where our CEO Avencia Sánchez-Mejías discusses how the company’s gene writing tool could improve advanced therapies for patients.

By Darcy Jimenez